eCite Digital Repository

Treatment with Etanercept in a Patient with Rheumatoid Arthritis-Associated Interstitial Lung Disease

Citation

Wang, Y and Xu, SQ and Xu, JH and Ding, C, Treatment with Etanercept in a Patient with Rheumatoid Arthritis-Associated Interstitial Lung Disease, Clinical Medicine Insights: Case Reports, 4 pp. 49-52. ISSN 1179-5476 (2011) [Contribution to Refereed Journal]


Preview
PDF
Pending copyright assessment - Request a copy
1Mb
  

DOI: doi:10.4137/CCRep.S8150

Abstract

We report a case of a 52-year-old woman with a 1-year history of rheumatoid arthritis-associated interstitial lung disease referred to hospital because of aggravated pulmonary symptoms in spite of intensive treatment including prednisone, azathioprine and triptergium glycoside. We subsequently initiated treatment with 25 mg of etanercept, subcutaneously injected twice weekly. Following 6 months of therapy with this agent, sustained improvement in dyspnea, cough was reported by the patient and respiratory function test showed marked improvement. The improvement was confirmed by reduced middle and lower lung markings on chest radiography and high-resolution CT scan. This report suggests etanercept may be effective in the treatment of rheumatoid arthritis-associated interstitial lung disease.

Item Details

Item Type:Contribution to Refereed Journal
Keywords:rheumatoid arthritis, interstitial lung disease, etanercept
Research Division:Medical and Health Sciences
Research Group:Clinical Sciences
Research Field:Rheumatology and Arthritis
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Skeletal System and Disorders (incl. Arthritis)
Author:Ding, C (Professor Chang-Hai Ding)
ID Code:75692
Year Published:2011
Deposited By:Menzies Institute for Medical Research
Deposited On:2012-02-09
Last Modified:2012-06-18
Downloads:0

Repository Staff Only: item control page